Background An aberrant interaction between commensal skin bacteria and the host skin immune system is consid-
Introduction
Hidradenitis Suppurativa (HS) is a chronic, debilitating skin disease characterized by recurrent abscesses, nodules, sinuses and scarring involving the intertriginous areas of the body. 1 Although HS is not considered to be a simple infection, bacteria are thought to play a role in the pathogenesis and an aberrant interaction of commensal skin bacteria with the innate skin immune system in patients with HS has been suggested as a central element of the pathogenesis of the disease. [2] [3] [4] This implies that both immune system and the commensal flora of HS patients may have functional characteristics which influence the pathogenesis of HS. Data on the role of the skin microbiome in the pathogenesis of other inflammatory skin diseases such as acne vulgaris, psoriasis and atopic dermatitis are currently emerging. 5 However,
Staphylococcus aureus and coagulase-negative staphylococci (CNS) are the most abundant species cultured from lesional skin of patients with HS. [6] [7] [8] Generally, Staphylococcus epidermidis is a non-pathogenic CNS and a part of the human skin microbiome. However, S. epidermidis can become pathogenic and cause severe infections especially in immunocompromised patients and in patients with implants. [9] [10] [11] [12] Biofilm formation is an important functional characteristic and a crucial virulence trait of S. epidermidis infections. 13 Biofilms are matrix-enclosed sessile microbial communities characterized by their ability to adhere to any surface and to each other. 14 The biofilm matrix consists of a mixture of exopolysaccharides, proteins, DNA and other macromolecules, which allows bacteria to evade the host immune system and antimicrobial exposure. 15 The clinical course of HS shows several characteristics of a biofilm-driven disease. The chronic and recurrent course of HS, the slow wound healing process and the relative resistance towards conventional antibiotic therapy are compatible with a pathogenic role for biofilms in HS. 16 In contrast to HS-prone skin where biofilm appears to be absent, 2 the presence of biofilm in chronic HS lesions has recently been described. 16, 17 The current concept of HS treatment is immunomodulatory and anti-inflammatory therapy, and the antibiotics commonly used to treat HS possess those properties. 18 Therefore, we aimed to characterize the in vitro antibiotic susceptibility pattern, the in vitro growth and biofilm-forming capabilities of S. epidermidis strains isolated from HS patients.
Material and methods
The study protocol has been approved by the ethical board of Region Zealand, Denmark (project number SJ-420), and the data protection agency of Denmark (REG-105-2014). Informed consent was obtained from all patients.
Skin biopsies, bacterial cultures and analyses
The S. epidermidis isolates were cultured from 4 mm punch biopsies from active HS lesions such as inflammatory nodules and/or sinuses and non-involved skin (i.e. at least 10 centimetres away from the lesional skin) of HS patients in the Dermatological Department of Roskilde Hospital, Denmark. One laboratory control strain of S. epidermidis, a gift from Anders Løbner-Olesen, Department of Biology, University of Copenhagen, was used as a control. Biopsies were cultured in an initial enrichment broth by incubating at 35°C with 5% CO 2 for 3 days followed by subcultures onto 5% blood and chocolate agar plates for up to 10 days and anaerobic plates, incubated under anaerobic conditions. Speciation of microorganisms was carried out by MALDI-TOF MS (Bruker Daltonics, Bremen, Germany). Organisms of the same species were deemed indistinguishable if they had the same colony morphology, the same basic biochemical features and an identical antibiogram.
Antimicrobial agents
The antimicrobial agents used for the disc diffusion assay were tetracycline, rifampicin and clindamycin (Neo-sensitabs ROSCO, Taastrup, Denmark). The same antibiotics, including doxycycline, were used in minimum inhibitory concentration (MIC) assays. The antibiotics were prepared and stored at À20°C according to the instructions of the manufacturer.
Planktonic growth
Each bacterial isolate was inoculated in 10 mL Mueller-Hinton-Broth (MHB) medium (BD diagnostics, Mississauga, Canada) and incubated overnight at 37°C with gentle shaking. The growth of all S. epidermidis strains was evaluated by measuring the optical density (OD) at 600 nm (Eppendorf BioPhotometer, Eppendorf, North America). The OD 600 nm values were measured at 0, 20, 40, 80, 120, 180, 360 and 1440 min. All experiments and measurements were carried out in duplicates.
Antimicrobial susceptibility testing-disc diffusion and minimum inhibitory concentration (MIC) assay
The antibiotic susceptibility for tetracycline, clindamycin and rifampicin was tested using the disc diffusion method. The inhibition zone diameters were measured, recorded and categorized as sensitive (S), intermediate (I) or resistant (R) according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. 19 The MIC was performed to test the susceptibility to doxycycline in the strains resistant to tetracycline. Additionally, the isolates selected for biofilm eradication were also tested to determine the MIC value. For the MIC assay, we used an adapted protocol from Mojsoska et al. 20 Bacterial suspensions in the range of 2-8 9 10 5 colony-forming units per mL (CFU/mL) were incubated with the antibiotics overnight. The MIC classification was based on the MIC breakpoints of the EUCAST. All these experiments were performed in triplicates.
Microtiter biofilm formation assay
The cultured bacteria were tested for their ability to produce biofilm using the crystal violet assay. Three different types of media-MHB, LB and tryptic soy broth media with additional glucose (TSB 1% glucose) (Sigma-Aldrich, Denmark)-were used to determine the optimal growth conditions. Overnight cultures were diluted (1 : 100) in fresh media and 100 lL was plated in a flat bottom 96-well plate. At time points 24 and 48 h, the bacterial suspension was removed, washed two times with PBS and stained with 125 lL crystal violet 0.1% for 10 min at room temperature. After staining, the wells were washed again with PBS. About 96% ethanol was added for 10 min at room temperature to solubilize crystal violet. OD 595 nm was read with a plate reader (Synergy HT BioTek Instruments, Inc, Vermont USA). The strains were classified as strong, moderate, weak and no biofilm producer. 21, 22 The experiments were performed in duplicate.
Microtiter biofilm eradication assay
A few cultured strains were assessed for their ability to eradicate biofilm. The selection of the strains was based on their resistance pattern. Diluted overnight bacterial cultures were (1 : 100) cultured in flat bottom 96-well plates at 37°C for 24 h. After removal of the bacterial suspension, the wells were washed gently with PBS and the antibiotics were added for biofilm breakdown.
The plate was further incubated as described in the biofilm growth curve section.
Data analysis
Data presented represent duplicates from at least three independent experiments. Statistical analysis was carried out using GraphPad Prism version 6.0.1 (GraphPad Software, Inc., San Diego, CA, USA) using the unpaired, two-tailed Student's t-test. p-values less than 0.05 are considered statistically significant.
Results

Characteristics of patients and the S. epidermidis isolates
Staphylococcus epidermidis was cultured in 16 of 26 patients (62%). Twenty-seven different S. epidermidis strains were identified: 16 (59%) from non-involved sites and 11 (41%) from lesional sites ( Table 1) . Eight of 16 patients (50%) did not receive any antibiotic treatment 1 month prior to the biopsies. Three patients (19%) were on oral tetracycline and one patient (6%) was using topical clindamycin. Information about antibiotic treatment at the time of biopsy is missing for four patients (25%). In six of 16 patients (38%), more than one strain was cultured from a non-involved or lesional biopsy. On average, more strains were cultured in the group on antibiotics (0.8 strain) compared to the group not on antibiotics (0.7 strain). However, in the group which did not use antibiotics, more strains were cultured in non-involved skin (one strain) in comparison with lesional skin (0.3 strain). This difference was not found in the patients with antibiotic use in the past (0.75 strain in both non-involved and lesional HS skin) (data not shown).
Planktonic growth
After 24 h, the strains reached an OD value between 2 and 5 on a scale from 0 to 5 (Fig. 1a) , with the laboratory control strain showing the highest OD measurement after 24 h.
Antimicrobial susceptibility
Twenty-six of 27 strains were sensitive to rifampicin (96%). Twenty of 27 strains (74%) were sensitive for tetracycline. Seven of 27 strains (26%) were classified as resistant (five strains) or intermediate (two strains) sensitive to tetracycline. The tetracycline-resistant strains were also resistant to doxycycline. Two strains from three patients with a known medical history of recent use of tetracycline use were classified as resistant. Three of 27 strains were sensitive for clindamycin (11%), whereas resistance (nine strains) and intermediate sensitivity (15 strains) were observed in 24 strains (24/27; 89%). A strain isolated from a patient with known previous topical use of clindamycin was resistant to that antibiotic (Table 1) . Proportional difference in susceptibility patterns between S. epidermidis strains from non-involved and lesional skin was demonstrated for all antibiotics, and in particular for clindamycin (Table 2) .
Biofilm production
Twenty-four of 27 clinical isolates (89%) could be classified as strong biofilm producers. The laboratory control strain was also categorized as a strong biofilm producer. Two strains, from two different patients, both from lesional HS sites, were classified as non-biofilm-forming strains (Table 1, Fig. 1b) . One strain, Control  71  74  75  76  77  78  79  91  92  95  96  97  100  108  110  111  72  73  93  94  98  99  101  107  109  112 The variation between the amount of biofilm is visible in both non-involved skin and lesional isolates. After 24 h, the biofilm production decreased in all strains (not shown). Fig. 1b) .
Biofilm eradication assay
Based on the biofilm growth curves and the MIC values, we selected bacterial isolates from two patients for the biofilm eradication assay, patient number 8 (strains 91, 92 and 93) and patient number 10 (strain number 96, 97 and 98). Patient 8 (unknown antibiotic use in past) and patient 10 (tetracycline antibiotic use in past) were selected because multiple strains were cultured from their skin biopsies and because strains from patient 8 showed a significantly different susceptibility pattern in the MIC compared to patient 10. The laboratory control strain served as a reference. Rifampicin and clindamycin eradicated the biofilm in a significant manner in all tested HS strains (P < 0.05, Fig. 2b,c) . Tetracycline also eradicated the biofilm significantly in almost all HS strains. Notably, tetracycline induced a significant increase in biofilm in one strain (patient 10, strain 96, P < 0.05, Fig. 2c) . Doxycycline eradicated the biofilm significantly (patient 10, strain 96, P < 0.05, Fig. 2c ). In two strains (strains 92 and 96), doxycycline was not eradicating the biofilm significantly (Fig. 2b,c) . Only tetracycline failed to eradicate biofilm in the laboratory control S. epidermidis strain (Fig. 2a) .
Discussion
The skin is colonized by a broad spectrum of microorganisms. Skin commensals mostly do not harm, live in symbiosis and in general are even beneficial to the host. An important host factor regulating the composition and balance of the skin commensals is the skin innate and adaptive immune response to microorganisms. 23 in the anogenital area), anaerobic commensals in lesional HS tissue. 7, 24, 25 Data suggest a shift in microbiota from preclinical paucity to an abundance in chronic lesions. 2, 17 An aberrant interaction between the commensal skin bacteria and the skin immune system has been suggested to play a role in HS. A current hypothesis is that in genetically susceptible individuals, follicular plugging and early inflammation are triggered by an abnormal immune response to intrafollicular skin commensals. 26 We investigated S. epidermidis because it is a natural constituent of the human skin microbiome, the follicular infundibulum and because it has been isolated from HS lesions. [27] [28] [29] Our finding that more than one S. epidermidis strain was cultured from non-involved and/or lesional skin in six HS patients indicates a polyclonal S. epidermidis population within the patient. 30 In healthy volunteers, it has also been shown that an individual can carry many S. epidermidis strains with differing antibiotic resistance patterns, capacities to form biofilm and overall gene distribution. 31 By growing the strains in a planktonic phase, we were able to analyse the strains in more detail, defining growth rates and antibiotic resistance patterns. Growth rates influence the virulence of bacteria as well as their antibiotic resistance. 32, 33 We included a laboratory control strain which grew to a higher optical density indicative of more exuberant growth than the HS strains and did not observe significant differences in growth rates between the strains isolated for lesional or non-lesional skin. Antibiotic susceptibility is another functional characteristic of bacteria. We tested the susceptibility towards the most commonly used antibiotic treatments of HS. The finding that 96 per cent of cultured S. epidermidis strains were sensitive to rifampicin is largely consistent with other studies that performed susceptibility testing on S. epidermidis strains. [34] [35] [36] However, none of these studies were on S. epidermidis strains from HS lesions. Nevertheless, it is an important and encouraging finding because rifampicin is an important antibiotic in different guidelines for the treatment of HS. Recent studies demonstrated acquired resistance for antibiotics by S. epidermidis. 10 The observed resistance for rifampicin illustrates the potential of S. epidermidis to transform from a commensal into a pathogen. The strains with resistance to tetracycline were also crossresistant to doxycycline. This resistance percentage is interesting as tetracyclines form a first line systemic antibiotic treatment for patients with HS and/or acne. One study investigated the resistance pattern of 129 isolates from HS lesions. Unfortunately, the authors did not specify the resistance pattern per bacterial species. From the 129 isolates, 42 were resistant to tetracycline (33%). 37 Clindamycin appeared as the weakest antibiotic with almost 90% of the strains showing an intermediate sensitivity to resistance. Resistance to clindamycin was significantly higher in our study, compared to Cavanagh et al. (33% vs. 8%) who investigated the antimicrobial susceptibility of S. epidermidis strains from healthy individuals. 36 High antimicrobial resistance to clindamycin has been observed in bacterial isolates obtained from HS patients. An overall resistance rate of 71 of 129 isolates (71%) was found. 37 In daily clinical practice, the combination therapy of rifampicin with clindamycin is often prescribed for the treatment of HS. Clindamycin is known to enhance the bactericidal properties of rifampicin in vitro. 38 Additionally, in vivo experiments have demonstrated synergistic bactericidal effects of rifampicin and clindamycin on S. aureus strains. 39 Regardless, only one isolated strain was cross-resistant towards both clindamycin and rifampicin. This strain was isolated from a patient that had no medical history of previous or ongoing rifampicin use, but had reported use of clindamycin lotion in the past, which could have induced the resistance to clindamycin. 40 Treatment of HS is mainly based on immunomodulatory and anti-inflammatory therapy, and not on the bacteriocidal of bacteriostatic effect of antibiotics. 18 Therefore, our findings regarding the antibacterial effect on our strains are of less importance in the treatment of HS, although it has profound importance when considering the escalating problems tied to antimicrobial resistance. Taking into consideration that biofilm formation is regarded as S. epidermidis most notable virulence trait, particularly in terms of medical treatment, the propensity to form biofilm could be considered an important virulence feature. Most of the S. epidermidis strains from HS patients were classified as strong biofilm producers in vitro. However, two strains, classified as non-biofilm producers, were isolated from lesional HS skin. Therefore, based on this study, it was not possible to relate biofilm formation to either lesional or non-involved skin or HS pathogenesis.
Rifampicin showed the highest biofilm eradication activity against strains from HS patients and also the laboratory control strain. Gomes et al. performed biofilm eradication by testing five S. epidermidis strains against eight antibiotics. Rifampicin appeared the most potent antibiotic used. 41 Similar results were obtained in another study. 42 Although different techniques were used in these two studies, they are in accordance with our results, emphasizing rifampicin's potency against S. epidermidis biofilms. Even though the tested HS strains had an intermediate to resistant response towards clindamycin when growing as individual bacteria, clindamycin eradicated the biofilm in all tested HS strains. A changed phenotype of bacteria that are embedded in the biofilm could have led to tolerance towards clindamycin. For instance, tolerance mechanisms in biofilms could involve reduced bacterial growth, the presence of persistent cells and mechanisms that control antibiotic-induced oxidative stress.
Interestingly, enhancement of biofilm formation was seen in only one strain. Previous studies have shown that antibiotics can increase the synthesis of the extracellular polymeric substance and biofilm formation by upregulating transcription genes responsible for different virulence factors in biofilm production. 44 One of the strengths of this study is that optimized conditions for culturing and biofilm testing of S. epidermidis were carefully chosen and tested for all the performed experiments. Secondly, we used a S. epidermidis laboratory control strain to increase the validity of our experimental set-up.
A limitation of this study is that we did not include biopsies of healthy controls without a (family) history of HS. By including healthy individuals, we could have made several comparisons with strains from non-involved skin from HS patients. Secondly, we tested a selection of the isolated strains for biofilm eradication, and we missed information about previous antibiotic use and medical history of a few included HS patients.
Summarizing, we observed a slight increase in S. epidermidis virulence, characterized by resistance to commonly used antibiotics, increased biofilm production and resistance to biofilm eradication. In particular, the reduced sensitivity to tetracycline and clindamycin, two key antibiotics used in supportive treatment of HS and acne, is alarming. Future larger case-control studies are needed focusing on functional characteristics, including the response of the skin immune system to S. epidermidis strains.
